Fotini Manizate, Spiros P Hiotis, Daniel Labow, Sasan Roayaie, Myron Schwartz
Journal: Oncology 2010;78 Suppl 1():131-4
PMID: 20616595
More than 90% of cases of hepatocellular carcinoma develop as a consequence of underlying liver disease (most commonly viral hepatitis), often resulting in impaired liver function. In such cases, transplantation is an appealing alternative as it can potentially treat both the malignancy and the underlying disease. When a transplant is not readily available due to organ scarcity, borderline cases must be considered for resection. The function of the underlying liver can be assessed by the Child-Pugh score or by quantitative tests such as indocyanine green clearance, lidocaine metabolism, and arterial body ketone ratio; liver biopsy pathology scoring and the platelet count can serve as indicators of fibrosis and portal hypertension. Another important factor to be considered is the risk of tumor recurrence, either because of unrecognized metastasis or due to de novo tumor formation. Both factors must be considered in weighing resection against nonsurgical alternatives. Preoperative portal vein embolization is a strategy that can evoke 'regeneration' in anticipation of surgery, serving as a 'stress test' of the liver's regenerative capacity.
Copyright (c) 2010 S. Karger AG, Basel.
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.